首页> 美国卫生研究院文献>Cancers >Targeting the Sonic Hedgehog Pathway to Suppress the Expression of the Cancer Stem Cell (CSC)—Related Transcription Factors and CSC-Driven Thyroid Tumor Growth
【2h】

Targeting the Sonic Hedgehog Pathway to Suppress the Expression of the Cancer Stem Cell (CSC)—Related Transcription Factors and CSC-Driven Thyroid Tumor Growth

机译:靶向Sonic Hedgehog途径以抑制癌症干细胞(CSC)相关的转录因子和CSC驱动的甲状腺肿瘤生长的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Poorly differentiated and anaplastic thyroid cancers respond poorly to surgery, radiation, and hormone therapy. Cancer stem cells play an important role in tumor growth, drug resistance, and recurrence. This study focuses on how the sonic hedgehog (Shh) pathway maintains thyroid cancer stem cell self-renewal and whether it can be targeted for anticancer therapy. The authors report that the Shh pathway regulates the expression of BMI1 and SOX2, two genes involved in stem cell self-renewal, and that targeting the Shh pathway has little effect on thyroid tumor xenografts but can inhibit the growth of tumor xenografts derived from thyroid cancer stem cells. This study advances the knowledge on how thyroid cancer stem cells regenerate and highlights the potential therapeutic values of targeting the Shh pathway.
机译:差异化差,甲状腺功能亢进癌症对手术,辐射和激素治疗不良反应。癌症干细胞在肿瘤生长,耐药性和复发中起着重要作用。本研究重点介绍了Sonic Hedgehog(SHH)途径如何维持甲状腺癌干细胞自我更新以及是否可以针对抗癌治疗。作者报告说,SHH途径调节BMI1和SOX2的表达,两个基因参与干细胞自我更新,靶向SHH途径几乎没有影响甲状腺肿瘤异种移植物,但可以抑制衍生自甲状腺癌的肿瘤异种移植物的生长干细胞。本研究提出了对甲状腺癌干细胞如何再生的知识,并突出靶向SHH途径的潜在治疗价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号